Table I.
Clinical and pathological features of the gastric cancer patientsa (n=90).
| Variable | No. of patients (%) |
|---|---|
| Sex | |
| Male | 69 (76.7) |
| Female | 21 (23.3) |
| Age (years) | |
| <70 | 45 (50) |
| ≥70 | 45 (50) |
| Differentiation | |
| G2 | 28 (31.1) |
| G3 | 62 (68.9) |
| Tumor size (cm) | |
| <5 | 35 (38.9) |
| ≥5 | 54 (60.0) |
| NA | 1 (1.1) |
| TNM stage | |
| I | 12 (13.3) |
| II | 27 (30.0) |
| III | 49 (54.5) |
| IV | 2 (2.2) |
| Tumor stage | |
| T1 | 5 (5.6) |
| T2 | 15 (16.7) |
| T3 | 46 (51.1) |
| T4 | 24 (26.6) |
| Nodal stage | |
| N0 | 24 (26.7) |
| N1 | 15 (16.7) |
| N2 | 23 (25.5) |
| N3 | 28 (31.1) |
| Vessel invasion | |
| No | 74 (82.2) |
| Yes | 16 (17.8) |
| Nerve invasion | |
| No | 74 (82.2) |
| Yes | 15 (16.7) |
| NA | 1 (1.1) |
| Expression of CPXM2 | |
| Low | 41 (45.6) |
| High | 49 (54.4) |
a
Data shown here may be duplicated with data from other published resources that are based on the same cohorts. NA, information not available; CPXM2, carboxypeptidase X, M14 family member 2; TNM, tumor node metastasis.